ArticleJournal of cellular and molecular medicine2023

miR-3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi-targets.

Ling Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.